Laman UtamaNHIQ • OTCMKTS
add
NantHealth Inc
Tutup sebelumnya
$0.00010
Julat hari
$0.00010 - $0.00010
Permodalan pasaran
2.75K USD
Bilangan Purata
187.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Sep 2023info | Perubahan T/T |
---|---|---|
Hasil | 12.47J | — |
Perbelanjaan pengendalian | 12.17J | — |
Pendapatan bersih | -14.99J | — |
Margin untung bersih | -120.20 | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -175.00K | — |
Kadar cukai berkesan | -0.36% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Sep 2023info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 5.82J | — |
Jumlah aset | 146.48J | — |
Jumlah liabiliti | 396.66J | — |
Jumlah ekuiti | -250.18J | — |
Syer tertunggak | 27.47J | — |
Harga kepada buku | -0.00 | — |
Pulangan pada aset | -8.24% | — |
Pulangan pada modal | -41.68% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Sep 2023info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -14.99J | — |
Tunai daripada operasi | -7.65J | — |
Tunai daripada pelaburan | 11.00K | — |
Tunai daripada pembiayaan | 7.50J | — |
Perubahan bersih dalam tunai | -298.00K | — |
Aliran tunai bebas | -3.94J | — |
Perihal
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Diasaskan
7 Jul 2010
Tapak web
Pekerja
373